The Forgotten eHealth Code of Ethics

Recently, I was sorry to see that the eHealth Code of Ethics, which I helped create back in 2000, was not included in the list of references to an article about...

FDA Has Many Hurdles to Overcome in its Effort to Stem the Current Opioid...

The FDA has made many efforts to deal with the current opioid addiction crisis. The latest is the establishment of a "Opioid Policy Steering Committee." Some of these efforts may have...

Farewell Pharma Friends! Beware of the PharmaGovernment Complex!

It's my 71st birthday and I decided it's a good time for me to move on to a new role. Unbelievable, right? John "PharmaGuy" Mack is seventy-one years old! Also unbelievable is...

Digital Health Publishers Just Got a Healthy Way to Drive New Visits

It’s no secret that digital health publishers of all types struggle to introduce new users to their content. Consumer traffic exchanges and content discovery engines have historically focused on every vertical except health and medicine. You can easily find dozens of networks that focus on fashion, sports, pop culture, technology or finance, but consumer health is MIA.

5 Strategies to Strengthen Relationships with HCPs

Increasing engagement with healthcare professionals (HCPs) online has become exceedingly difficult over the past 5 years. There are many websites and e-newsletters competing for a physician’s attention. HCPs are...

Why Has There Been a Drop in FDA Enforcement Activity?

That's one question on the mind of EyeOnFDA author Mark Senak of FleishmanHillard's Washington, D.C. office. Senak plotted the number of "Action Letters," which are Warning Letters to drug company CEOs...

Dancing with Fentanyl: Insys Sales Reps Caught Rapping to Boost Sales

You can't make this stuff up! According to Huffington Post, "Pharmaceutical sales representatives selling an opioid-based drug 50 times more powerful than heroin filmed a company-made rap video in which they danced...

Purdue’s Opioid Marketing is Target of a Federal Criminal Probe

As reported by Bloomberg: Federal prosecutors in Connecticut began a criminal investigation into Purdue Pharma Inc.’s marketing of the controversial opioid painkiller OxyContin. U.S. Attorney Deirdre Daly is gathering documents about Purdue’s claim that...

What’s New at EHS?

Tap Native Selects eHealthcare Solutions to Deliver its Unique In-Content Native Advertising Opportunities to Pharma Brands eHealthcare Solutions (EHS) recently announced an exclusive partnership with Tap Native....

“Fake Advertising”: Allergan Should Be Red in the Face for Using “Before & After”...

Allergan is again resorting to side-by-side "before and after” images in a drug ad to prove that Rhofade - its new drug for the treatment of redness of the face, aka...

Pharma Marketing News, Blog Posts, Events, Podcasts

- Advertisement -